The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.

The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.

Bibliographic Details
Main Authors: Habib, N. A., Hershman, M. J., Haberland, F., Papp, L., Wood, C. B., Williamson, R. C.
Format: Online
Language:English
Published: 1986
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001389/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001389/

Similar Items